Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 234
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05614752 | Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT02415777 | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction | ||
| NCT02947620 | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT05699070 | Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects | ||
| NCT01629875 | Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line | ||
| NCT06671392 | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension | ||
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. | ||
| NCT06751121 | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori | ||
| NCT05192395 | A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers | ||
| NCT03753477 | Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 | ||
| NCT06121830 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) | ||
| NCT04888819 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT02947815 | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT01635686 | Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers | ||
| NCT01423526 | A Single Dose Study of DWP10292 in Healthy Male Subjects | ||
| NCT01634308 | Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation | ||
| NCT06399835 | Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis | ||
| NCT05993247 | Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients | ||
| NCT07371104 | Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer | ||
| NCT01654640 | The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine | ||
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | ||
| NCT02693522 | Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency | ||
| NCT04294251 | Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy | ||
| NCT04541485 | To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) | ||
| NCT07013279 | Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines | ||
| NCT05889143 | A Study to Evaluate the Efficacy and Safety of CREZET Tablet | ||
| NCT03369990 | DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy | ||
| NCT07479056 | Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy | ||
| NCT03439020 | The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent | ||
| NCT02952547 | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT03029533 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT02568150 | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | ||
| NCT07213310 | Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults | ||
| NCT06627322 | A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | ||
| NCT05614778 | Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis | ||
| NCT02490111 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | ||
| NCT05672836 | ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement | ||
| NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
| NCT06036342 | Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination | ||
| NCT01653314 | Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers | ||
| NCT02385032 | Comparative Bioavailability Study of UDCA | ||
| NCT07326904 | Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease | ||
| NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT06109259 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers | ||
| NCT04477369 | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers | ||
| NCT04632862 | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | ||
| NCT04159961 | Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers |
